734150006: Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\...

\Cytochrome P450 inhibitor-containing product\Cobicistat-containing product\...

\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\Integrase strand transfer inhibitor-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\Integrase strand transfer inhibitor-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Nucleotidyltransferase inhibitor-containing product\Integrase strand transfer inhibitor-containing product\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Emtricitabine-containing product\Emtricitabine-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Tenofovir-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Transferase inhibitor-containing product\Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Medicinal product categorised by structure\Ether structure-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Ether structure-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Ether structure-containing product\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Cobicistat-containing product\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Tenofovir-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Urea and/or urea derivative-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Urea and/or urea derivative-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Urea and/or urea derivative-containing product\Cobicistat-containing product\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Chlorine and/or chlorine compound-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Chlorine and/or chlorine compound-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Chlorine and/or chlorine compound-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Emtricitabine-containing product\Emtricitabine-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Quinoline-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Quinoline-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Quinoline-containing product\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Halogenated hydrocarbon-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Halogenated hydrocarbon-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Halogenated hydrocarbon-containing product\Chlorinated hydrocarbon-containing product\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Thiazole-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Thiazole-containing product\Cobicistat-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Thiazole-containing product\Cobicistat-containing product\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Medicinal product categorised by therapeutic role\Antiviral agent\Antiretroviral agent\...

\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Elvitegravir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Elvitegravir-containing product\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Emtricitabine-containing product\Emtricitabine-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Emtricitabine-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Tenofovir-containing product\Tenofovir-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Tenofovir-containing product\Emtricitabine- and tenofovir-containing product\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Product manufactured as oral dose form\Emtricitabine-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form\Tenofovir-containing product in oral dose form\Emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

Status: current, Defined. Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3487411011 Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet en Synonym Active Case insensitive SNOMED CT core

3677808015 Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Is a	Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Plays role	Antiretroviral therapeutic role	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Cobicistat	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Emtricitabine	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Emtricitabine	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Cobicistat	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Is a	Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	false	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has active ingredient	Cobicistat	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Cobicistat	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	150	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has active ingredient	Elvitegravir	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Elvitegravir	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	150	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has active ingredient	Emtricitabine	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Emtricitabine	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	200	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has active ingredient	Tenofovir alafenamide	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Tenofovir alafenamide	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	10	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Is a	Product manufactured as oral dose form	false	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has unit of presentation	Tablet	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	150	false	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	150	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Cobicistat	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Cobicistat	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Emtricitabine	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	200	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Elvitegravir	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Elvitegravir	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Emtricitabine	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value	10	false	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Tenofovir alafenamide	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has BoSS	Tenofovir alafenamide	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Count of base of active ingredient	4	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3487411011	Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core
3677808015	Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core